Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide

European Journal of Pharmaceutical Sciences

Volumn 99, Issue , 2017, Pages 75-84

  Kassem, Ahmed Alaa ^a   Abd El Alim, Sameh Hosam ^a   Basha, Mona ^a   Salama, Abeer ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Antidiabetic effect; Hypoglycemic activity; Lipid profile; Micelles; Phospholipid complex; Repaglinide

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PHOSPHOLIPID; POLOXAMER; REPAGLINIDE; SOLVENT; ANTIDIABETIC AGENT; CARBAMIC ACID DERIVATIVE; DRUG CARRIER; MICELLE; PIPERIDINE DERIVATIVE; TABLET;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG STABILITY; EVAPORATION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; NANOENCAPSULATION; NONHUMAN; PH; PRIORITY JOURNAL; RAT; X RAY POWDER DIFFRACTION; ZETA POTENTIAL; ANIMAL; CHEMISTRY; MEDICINAL CHEMISTRY; MICELLE; PROCEDURES; TABLET; TRANSMISSION ELECTRON MICROSCOPY; WISTAR RAT; X RAY DIFFRACTION;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CARBAMATES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HYPOGLYCEMIC AGENTS; MALE; MICELLES; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHOLIPIDS; PIPERIDINES; POLOXAMER; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 85006355984     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2016.12.005     Document Type: Article

References (80)

1. Aditya, N.P., Shim, M., Lee, I., Lee, Y., Im, M.H., Ko, S., Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. J. Agric. Food Chem. 61 (2013), 1878–1883.
2. Ahmadvand, H., Tavafi, M., Khosrowbeygi, A., Shahsavari, G., Hormozi, M., Beyranvand, K., Bagheri, S., Abdolahpour, F., Amelioration of lipid peroxidation in vivo and in vitro by Satureja khozestanica essential oil in alloxan-induced diabetic rats. J. Diabetes Metab. Disord., 13, 2014, 119.
3. Bako, H., Mohammad, J., Wazir, P., Bulus, T., Gwarzo, M., Zubairu, M., Lipid profile of alloxan-induced diabetic wistar rats treated with methanolic extract of Adansonia digitata fruit pulp. Sci. World J. 9 (2014), 19–24.
4. Basalious, E.B., Shamma, R.N., Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: in vitro characterization, ex vivo transport and in vivo pharmacokinetic studies. Int. J. Pharm. 493 (2015), 347–356.
5. Bidstrup, T.B., Bjornsdottir, I., Sidelmann, U.G., Thomsen, M.S., Hansen, K.T., CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. Br. J. Clin. Pharmacol. 56 (2003), 305–314.
6. Bodade, S.S., Shaikh, K.S., Kamble, M.S., Chaudhari, P.D., A study on ethosomes as mode for transdermal delivery of an antidiabetic drug. Drug Deliv. 20 (2013), 40–46.
7. Cai, X., Luan, Y., Jiang, Y., Song, A., Shao, W., Li, Z., Zhao, Z., Huperzine A-phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release. Int. J. Pharm. 433 (2012), 102–111.
8. Cheng, L., Xu, P.H., Shen, B.D., Shen, G., Li, J.J., Qiu, L., Liu, C.Y., Yuan, H.L., Han, J., Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride. Int. J. Pharm. 489 (2015), 148–157.
9. Chukwunonso Obi, B., Chinwuba Okoye, T., Okpashi, V.E., Nonye Igwe, C., Olisah Alumanah, E., Comparative study of the antioxidant effects of metformin, glibenclamide, and repaglinide in alloxan-induced diabetic rats. J. Diab. Res. 2016 (2016), 1–5.
10. De Berardis, G., D'Ettorre, A., Graziano, G., Lucisano, G., Pellegrini, F., Cammarota, S., Citarella, A., Germinario, C.A., Lepore, V., Menditto, E., Nicolosi, A., Vitullo, F., Nicolucci, A., The burden of hospitalization related to diabetes mellitus: a population-based study. Nutr. Metab. Cardiovasc. Dis. 22 (2012), 605–612.
11. DeFronzo, R.A., Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 131 (1999), 281–303.
12. Desai, N.S., Nagarsenker, M.S., Design and evaluation of self-nanoemulsifying pellets of repaglinide. AAPS PharmSciTech 14 (2013), 994–1003.
13. Dhana lekshmi, U.M., Poovi, G., Kishore, N., Reddy, P.N., In vitro characterization and in vivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles. Int. J. Pharm. 396 (2010), 194–203.
14. Ebrahimi, H.A., Javadzadeh, Y., Hamidi, M., Jalali, M.B., Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles. DARU. J. Pharm. Sci. 23:46 (2015), 1–11.
15. Elhenawy, A.A., Salama, A.A.A., All, M.M.A., Alomri, A.A., Nassar, H.S., Synthesis, characterization and discovery novel anti-diabetic and anti-hyperlipidemic thiazolidinedione derivatives. Int. J. Pharm. Sci. Rev. Res. 31 (2015), 23–30.
16. Erejuwa, O.O., Sulaiman, S.A., Wahab, M.S., Salam, S.K., Salleh, M.S., Gurtu, S., Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 11 (2010), 2056–2066.
17. Fernandes, N.P., Lagishetty, C.V., Panda, V.S., Naik, S.R., An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complement. Altern. Med. 7 (2007), 29–36.
18. Gadadare, R., Mandpe, L., Pokharkar, V., Ultra rapidly dissolving repaglinide nanosized crystals prepared via bottom-up and top-down approach: influence of food on pharmacokinetics behavior. AAPS PharmSciTech 16 (2015), 787–799.
19. Gandhi, G.R., Sasikumar, P., Antidiabetic effect of Merremia emarginata Burm. F. in streptozotocin induced diabetic rats. Asian Pac. J. Trop. Biomed. 2 (2012), 281–286.
20. Gonzalez-Mira, E., Egea, M.A., Garcia, M.L., Souto, E.B., Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf. B: Biointerfaces 81 (2010), 412–421.
21. Gumieniczek, A., Effects of repaglinide on oxidative stress in tissues of diabetic rabbits. Diabetes Res. Clin. Pract. 68 (2005), 89–95.
22. Guo, B., Liu, H., Li, Y., Zhao, J., Yang, D., Wang, X., Zhang, T., Application of phospholipid complex technique to improve the dissolution and pharmacokinetic of probucol by solvent-evaporation and co-grinding methods. Int. J. Pharm. 474 (2014), 50–56.
23. Hatorp, V., Oliver, S., Su, C., Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers. Int. J. Clin. Pharmacol. Ther. 36 (1998), 636–641.
24. He, W., Huang, S., Zhou, C., Cao, L., Yao, J., Zhou, J., Wang, G., Yin, L., Bilayer matrix tablets for prolonged actions of metformin hydrochloride and repaglinide. AAPS PharmSciTech 16 (2015), 344–353.
25. He, W., Wu, M., Huang, S., Yin, L., Matrix tablets for sustained release of repaglinide: preparation, pharmacokinetics and hypoglycemic activity in beagle dogs. Int. J. Pharm. 478 (2015), 297–307.
26. Jain, S., Saraf, S., Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus. J. Diab. 1 (2009), 29–35.
27. Jain, S.K., Agrawal, G.P., Jain, N.K., A novel calcium silicate based microspheres of repaglinide: in vivo investigations. J. Control. Release 113 (2006), 111–116.
28. Jain, S.K., Awasthi, A.M., Jain, N.K., Agrawal, G.P., Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J. Control. Release 107 (2005), 300–309.
29. Kamel, R., Mostafa, D.M., Rutin nanostructured lipid cosmeceutical preparation with sun protective potential. J. Photochem. Photobiol. B Biol. 153 (2015), 59–66.
30. Kandeil, M.A., Amin, K.A., Hassanin, K.A., Ali, K.M., Mohammed, E.T., Role of lipoic acid on insulin resistance and leptin in experimentally diabetic rats. J. Diabetes Complicat. 25 (2011), 31–38.
31. Kesarwani, K., Gupta, R., Mukerjee, A., Bioavailability enhancers of herbal origin: an overview. Asian Pac. J. Trop. Biomed. 3 (2013), 253–266.
32. Kliber, A., Szkudelski, T., Chichłowska, J., Alloxan stimulation and subsequent inhibition of insulin release from in situ perfused rat pancreas. J. Physiol. Pharmacol. 47 (1996), 321–328.
33. Korsmeyer, R.W., Gurny, R., Doelker, E., Buri, P., Peppas, N.A., Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15 (1983), 25–35.
34. Kramer, C.K., Zinman, B., Gross, J.L., Canani, L.H., Rodrigues, T.C., Azevedo, M.J., Retnakaran, R., Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis. BMJ 346 (2013), 1–13.
35. Kulkarni, R.V., Patel, F.S., Nanjappaiah, H.M., Naikawadi, A.A., In vitro and in vivo evaluation of novel interpenetrated polymer network microparticles containing repaglinide. Int. J. Biol. Macromol. 69 (2014), 514–522.
36. Lalau, J.D., Azzoug, M.L., Kajbaf, F., Briet, C., Desailloud, R., Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation. Diabete Metab. 40 (2014), 220–223.
37. Leroueil-Le Verger, M., Fluckiger, L., Kim, Y.I., Hoffman, M., Maincent, P., Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur. J. Pharm. Biopharm. 46 (1998), 137–143.
38. Liu, M., Cao, W., Sun, Y., He, Z., Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-beta-cyclodextrin. Int. J. Pharm. 477 (2014), 159–166.
39. Lokhande, A.B., Mishra, S., Kulkarni, R.D., Naik, J.B., Preparation and characterization of repaglinide loaded ethylcellulose nanoparticles by solvent diffusion technique using high pressure homogenizer. J. Pharm. Res. 7 (2013), 421–426.
40. Maiti, K., Mukherjee, K., Gantait, A., Saha, B.P., Mukherjee, P.K., Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 330 (2007), 155–163.
41. Mandic, Z., Gabelica, V., Ionization, lipophilicity and solubility properties of repaglinide. J. Pharm. Biomed. Anal. 41 (2006), 866–871.
42. Mata, J.P., Majhi, P.R., Guo, C., Liu, H.Z., Bahadur, P., Concentration, temperature, and salt-induced micellization of a triblock copolymer Pluronic L64 in aqueous media. J. Colloid Interface Sci. 292 (2005), 548–556.
43. Montasser, I., Fessi, H., Coleman, A.W., Atomic force microscopy imaging of novel type of polymeric colloidal nanostructures. Eur. J. Pharm. Biopharm. 54 (2002), 281–284.
44. Munyendo, W.L., Zhang, Z., Abbad, S., Waddad, A.Y., Lv, H., Baraza, L.D., Zhou, J., Micelles of TPGS modified apigenin phospholipid complex for oral administration: preparation, in vitro and in vivo evaluation. J. Biomed. Nanotechnol. 9 (2013), 2034–2047.
45. Pan, X., Yu, S., Yao, P., Shao, Z., Self-assembly of beta-casein and lysozyme. J. Colloid Interface Sci. 316 (2007), 405–412.
46. Pareek, H., Sharma, S., Khajja, B.S., Jain, K., Jain, G.C., Evaluation of hypoglycemic and anti-hyperglycemic potential of Tridax procumbens (Linn.). BMC Complement. Altern. Med. 9 (2009), 48–54.
47. Peppas, N.A., Sahlin, J.J., A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm. 57 (1989), 169–172.
48. Qin, L., He, H., Tang, X., Phospholipid solubilization of both poorly water-soluble and poorly oil-soluble drug into oils using freeze-drying technology. AJPS 1 (2006), 103–109.
49. Rauscher, F.M., Sanders, R.A., Watkins, J.B. 3rd, Effects of new antioxidant compounds PNU-104067F and PNU-74389G on antioxidant defense in normal and diabetic rats. J. Biochem. Mol. Toxicol. 14 (2000), 189–194.
50. Rawat, M.K., Jain, A., Singh, S., In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats. J. Pharm. Sci. 100 (2010), 2406–2417.
51. Rawat, M.K., Jain, A., Mishra, A., Muthu, M.S., Singh, S., Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method. Curr. Drug. Deliv. 7 (2010), 44–50.
52. Rawat, M.K., Jain, A., Singh, S., Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation. J. Pharm. Sci. 100 (2011), 2366–2378.
53. Rawat, D.S., Thakur, B.K., Semalty, M., Semalty, A., Badoni, P., Rawat, M.S., Baicalein-phospholipid complex: a novel drug delivery technology for phytotherapeutics. Curr. Drug Discov. Technol. 10 (2013), 224–232.
54. Rizzo, M.R., Barbieri, M., Grella, R., Passariello, N., Paolisso, G., Repaglinide has more beneficial effect on cardiovascular risk factors than glimepiride: data from meal-test study. Diabete Metab. 31 (2005), 255–260.
55. Ruzilawati, A.B., Wahab, M.S.A., Imran, A., Ismail, Z., Gan, S.H., Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies. J. Pharm. Biomed. Anal. 43 (2007), 1831–1835.
56. Salama, A.A.A., Arbid, M.S., Protective effect of Al-hagi graecorum in alloxan-induced diabetic rats. Der. Pharma. Chemica 8 (2016), 8–15.
57. Sangsen, Y., Wiwattanawongsa, K., Likhitwitayawuid, K., Sritularak, B., Graidist, P., Wiwattanapatapee, R., Influence of surfactants in self-microemulsifying formulations on enhancing oral bioavailability of oxyresveratrol: studies in Caco-2 cells and in vivo. Int. J. Pharm. 498 (2016), 294–303.
58. Saravanakumar, G., Min, K.H., Min, D.S., Kim, A.Y., Lee, C.M., Cho, Y.W., Lee, S.C., Kim, K., Jeong, S.Y., Park, K., Park, J.H., Kwon, I.C., Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. J. Control. Release 140 (2009), 210–217.
59. Saravanan, R., Pari, L., Antihyperlipidemic and antiperoxidative effect of Diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats. BMC Complement. Altern. Med. 5 (2005), 14–21.
60. Scott, L.J., Repaglinide. Drugs 72 (2012), 249–272.
61. Seedher, N., Kanojia, M., Micellar solubilization of some poorly soluble antidiabetic drugs: a technical note. AAPS PharmSciTech 9 (2008), 431–436.
62. Semalty, A., Semalty, M., Rawat, B.S., Singh, D., Rawat, M.S., Pharmacosomes: the lipid-based new drug delivery system. Expert Opin. Drug Deliv. 6 (2009), 599–612.
63. Semalty, A., Semalty, M., Singh, D., Rawat, M.S., Development and physicochemical evaluation of pharmacosomes of diclofenac. Acta Pharm. 59 (2009), 335–344.
64. Sharma, M., Kohli, S., Dinda, A., In-vitro and in-vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer. Saudi Pharma. J. 23 (2015), 675–682.
65. Singh, C., Bhatt, T.D., Gill, M.S., Suresh, S., Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation. Int. J. Pharm. 460 (2014), 220–227.
66. Sinswat, P., Matteucci, M.E., Johnston, K.P., Williams, R.O., Dissolution rates and supersaturation behavior of amorphous repaglinide particles produced by controlled precipitation. J. Biomed. Nanotechnol. 3 (2007), 18–27.
67. Takahashi, Y., Furuya, K., Iwata, M., Onishi, H., Machida, Y., Shirotake, S., Trial for transdermal administration of sulfonylureas. J. Pharm. Soc. Jpn. 117 (1997), 1022–1027.
68. Tan, Q., Liu, S., Chen, X., Wu, M., Wang, H., Yin, H., He, D., Xiong, H., Zhang, J., Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech 13 (2012), 534–547.
69. Torchilin, V.P., Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 24 (2007), 1–16.
70. Vijayan, V., Reddy, K.R., Sakthivel, S., Swetha, C., Optimization and characterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patches: in vitro and in vivo studies. Colloids Surf. B: Biointerfaces 111 (2013), 150–155.
71. Xia, H.J., Zhang, Z.H., Jin, X., Hu, Q., Chen, X.Y., Jia, X.B., A novel drug-phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo. Int. J. Nanomedicine 8 (2013), 545–554.
72. Xu, W., Ling, P., Zhang, T., Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J. Drug Deliv., 2013, 2013, 340315.
73. Zhang, H., Bu, P., Xie, Y.H., Luo, J., Lei, M.X., Mo, Z.H., Liao, E.Y., Effect of repaglinide and gliclazide on glycaemic control, early-phase insulin secretion and lipid profiles in. Chin. Med. J. 124 (2011), 172–176.
74. Zhang, K., Gu, L., Chen, J., Zhang, Y., Jiang, Y., Zhao, L., Bi, K., Chen, X., Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats. J. Pharm. Biomed. Anal. 114 (2015), 168–175.
75. Zhang, J.Q., Liu, J., Li, X.L., Jasti, B.R., Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug Deliv. 14 (2007), 381–387.
76. Zhao, Y.Q., Wang, L.P., Ma, C., Zhao, K., Liu, Y., Feng, N.P., Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers. Int. J. Nanomedicine 8 (2013), 4169–4181.
77. Zheng, W., Wang, S.Y., Antioxidant activity and phenolic compounds in selected herbs. J. Agric. Food Chem. 49 (2001), 5165–5170.
78. Zhou, H., Wan, J., Wu, L., Yi, T., Liu, W., Xu, H., Yang, X., A new strategy for enhancing the oral bioavailability of drugs with poor water-solubility and low liposolubility based on phospholipid complex and supersaturated SEDDS. PLoS One, 8, 2013, e84530.
79. Zhu, Z., Yang, T., Zhao, Y., Gao, N., Leng, D., Ding, P., A simple method to improve the dissolution ofآ repaglinide and exploration of its mechanism. Asian J. Pharm. Sci. 9 (2014), 218–225.
80. Zhu, H., Zhang, X., Li, M.Z., Xie, J., Yang, X.L., Prevalence of type 2 diabetes and pre-diabetes among overweight or obese children in Tianjin, China. Diabet. Med. 30 (2013), 1457–1465.